Litigation

Arpan Sura focuses his practice on complex commercial litigation, with a particular emphasis on disputes in the financial services and digital technology sectors. He represents clients in business litigation and arbitration; intellectual property litigation; securities litigation and enforcement matters; and a wide range of government  investigations. Mr. Sura also maintains a robust pro bono practice, representing those adversely affected by governmental action at the administrative, trial, and appellate levels. 

Mr. Sura is a graduate of William & Mary Law School, where he served as the lead articles editor of the William & Mary Law Review.

Litigation Representative Matters

Commercial Litigation and Arbitration

• Represented Vietnamese business as trial counsel in a three-day International Chamber of Commerce arbitration relating to breach of contract in the market for higher education services. 
• Represents independent federal agency in multistate class action and appellate litigation relating to the tax and penalty immunities of federally-chartered corporations.
• Represents real estate investment trust in shareholder class action relating to the valuation of certain securities. 
• Represents financial institution in multidistrict antitrust class action litigation and state court proceedings relating to allegations of bid-rigging in the financial markets.

Digital Technology

• Represents leading software company in patent infringement actions relating to data processing systems.
• Represents patent owner in infringement actions relating to computer algorithms for intext, dynamic advertising.
• Assisted telecommunications provider in regulatory analysis of laws relating to wireless, satellite, and video programming. 

Investigation and Enforcement

• Represented businesses under investigation by the Securities and Exchange Commission, including investigations relating to the Foreign Corrupt Practices Act.
• Represented pharmaceutical companies under criminal and congressional investigations for the marketing and promotion of their drugs.